Recognizing The Month Of April 2024 As "parkinson's Disease Awareness Month" In The State Of The Delaware.
The resolution serves to acknowledge and support the Parkinson Foundation's efforts in raising awareness about PD. It emphasizes the economic burden of PD, projected to reach $80 billion annually in the U.S. by 2037, thus highlighting the relevance of community awareness in addressing the health impacts and costs associated with the disease. While it does not create new laws, its recognition of the month for awareness can lead to increased funding for research and support services.
SCR136 is a Senate Concurrent Resolution recognizing April 2024 as 'Parkinson's Disease Awareness Month' in the State of Delaware. The resolution highlights the significance of Parkinson's Disease (PD), a chronic and progressive condition affecting the nervous system, which manifests in various symptoms such as tremors, rigidity, and impaired motor functions. With an estimated 2,550 Delaware residents diagnosed and over 10 million people affected globally, the resolution aims to bring public awareness to this increasingly common disease.
The sentiment surrounding SCR136 is generally positive, with strong bipartisan support among the sponsors from both the Senate and House. The resolution aligns with broader efforts to improve public health through education and advocacy, making it a significant step towards fostering understanding of Parkinson's Disease within the state. Lawmakers see it as an opportunity to unite in support of those affected by PD and to promote ongoing discussions about health and wellness.
While SCR136 is largely non-controversial, discussions may revolve around the adequacy of state support for healthcare issues like PD. Some advocates may argue for more comprehensive funding for PD research and treatment, pushing for the need to translate awareness into tangible healthcare advancements. This resolution has sparked proactive conversations about health preparedness and community resources needed to tackle PD and other neurodegenerative diseases effectively.